Zantac Lawsuit
Zantac Lawsuits
Zantac Lawsuits
A Zantac lawsuit is a legal claim filed by people who developed cancer after taking Zantac and ranitidine tainted with NDMA. Zantac lawsuits seek compensation from the drug makers for cancers of the bladder, stomach, esophagus, liver, and pancreas that may have been caused by NDMA exposure.
PFAS Lawsuit Facts
PFAS (per- and polyfluoroalkyl substances) are a group of man-made chemicals used in various industrial applications and consumer products.
PFAS exposure has been linked to several health issues, including certain cancers, thyroid disease, and reproductive problems.
Exposure can occur through contaminated drinking water, food packaging, and certain consumer products. Testing may be available for affected individuals.
Who Is Eligible to File a Lawsuit?
People must meet several prerequisites, according to Zantac lawyers, in order to be eligible for a lawsuit: documented Zantac use, a cancer diagnosis, and a link between the disease and Zantac. Lawyers are only considering claims from persons who used the brand-name Zantac, and generic ranitidine is no longer covered.
Only a lawyer can correctly evaluate a claim, as well as assist in the collection of medical documents and data needed to develop a case.
Cancers that qualify for Zantac lawsuits include:
- Bladder
- Gastric/Stomach
- Esophageal
- Liver
- Pancreatic
Free Case Review
According to Zantac lawyers, several doctors who diagnosed persons with cancer after taking Zantac indicated they had no family history or genetic indications for cancer. Instead, doctors told patients that the illness was due to something in their surroundings, such as NDMA poisoning.